Copies of letters sent to UK healthcare professionals in August 2012, to inform of new safety information and advice include:
| Date sent | Medicine | Safety information |
|---|---|---|
| 6 August 2012 | Ondansetron (262Kb) |
QTC prolongation – new dose restriction for intravenous ondansetron given for chemotherapy-induced nausea and vomiting in adults |
| 22 August 2012 | Tamiflu (322Kb) |
Concentration of oral suspension to be changed from 12 mg/mL to 6 mg/mL |
| 24 August 2012 | Depocyte (203Kb) |
Possible risk of sterility failure at manufacturing site – product recall in Europe |
| 28 August 2012 | Calcitonin (397Kb) |
Increased risk of malignancies with the long-term use of calcitonin. Calcitonin should no longer be used in the treatment of osteoporosis. |